ARTICLE | Clinical News
Remune: IMNR started a Phase III trial
March 25, 1996 8:00 AM UTC
The Immune Response Corp. (IMNR), Carlsbad, Calif. Product: Remune, inactivated HIV stripped of gp120 envelope protein Indication: HIV Status: IMNR started a Phase III trial with its Remune therapeuti...